Applicable to Various Molecular Types
The CANDDIE Platform Service supports binding affinity prediction for various therapeutic modalities.
Antibody
Antibody Therapeutics
Chemical
Small Molecule Compounds
Peptide
Peptides
Affibody
Affibodies
Optimized Specifically for GPCRs
The CANDDIE Platform Service is equipped with optimized algorithms for membrane proteins, especially GPCR targets. It provides GPCR-specific technologies such as optimal biomembrane formation using InflateGro, distance restraints to preserve the native structure, and segmented production runs.
Increase Your Drug Development Success Rate
with the CANDDIE Platform Service
Rapid Prediction
Accurately calculates the binding affinity of GPCR systems in approximately 4 days or less.
High Accuracy
Provides validated prediction performance through a high correlation coefficient (R2 > 0.7) with experimental data.
Scientific Reliability
Validated through over 10 years of GPCR research and numerous SCI-level publications.
The CANDDIE Platform Service raises the initial design standard, lowering the probability of failure in subsequent research stages, and enabling companies to allocate R&D resources more strategically.